{
 "PrintNo":"A8932","Session":2019,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2020-01-02T15:14:20.934246Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2020-01-08","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2020-01-02","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO HEALTH","Date":"2020-01-08","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":574,"Name":"William A. Barclay","Short":"BARCLAY"}],
 "Title":"Relates to designating an individual to be notified in the case of dose or brand change for psychotropic medication",
 "Summary":"Relates to designating an individual to be notified in the case of dose or brand change for psychotropic medication.",
 "LawSection":"Public Health Law","LawCode":"Amd ยง2803-c, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to designating an individual to be notified in the case of dose or brand change for psychotropic medication"
}